HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Extract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                What's this?

Summary of Revisions for the 2005 Clinical Practice Recommendations

	INTRODUCTION

TOP INTRODUCTION Additions to the Standards... Summary of Revisions to... Members of the Professional...

	Additions to the Standards of Medical Care in Diabetes

TOP INTRODUCTION Additions to the Standards... Summary of Revisions to... Members of the Professional...

 

• Screening for diabetes
  
• Prevention of type 2 diabetes
  
• Psychosocial assessment and care
  
• Diabetes Care in specific populations
  • Children and adolescents with type 1 diabetes
    
  
  
• Diabetes in specific settings
  • Hospitals
    
  • Schools/Day care
    
  • Camps
    
  • Correctional institutions
    
  
  

	Summary of Revisions to Standards of Medical Care for Diabetes

TOP INTRODUCTION Additions to the Standards... Summary of Revisions to... Members of the Professional...

 

• Medical Nutrition Therapy (MNT): Expanded to discuss more fully the role of carbohydrates in the diet of those with diabetes and the role of lifestyle modification in obesity prevention and management.
  
• Lipid management: Updated recommendations based on recent studies (including the CARDS study) to include the following.
  • In individuals with diabetes aged >40 years with a total cholesterol 135 mg/dl, without overt cardiovascular disease, statin therapy to achieve an LDL reduction of 30–40% regardless of baseline LDL levels is recommended. The primary goal is an LDL <100 mg/dl (2.6 mmol/l).
    
  • For persons with diabetes aged <40 years without overt cardiovascular disease, but at increased risk (due to other cardiovascular risk factors or long duration of diabetes), who do not achieve lipid goals with lifestyle modifications alone, the addition of pharmacological therapy is appropriate and the primary goal is an LDL cholesterol <100 mg/dl (2.6 mmol/l).
    
  • People with diabetes and overt cardiovascular disease are at very high risk for further events and should be treated with a statin. A lower LDL cholesterol goal of <70 mg/dl (1.8 mmol/l), using a high dose of a statin, is an option in these high-risk patients with diabetes and overt cardiovascular disease.
    
  
  

	Members of the Professional Practice Committee

TOP INTRODUCTION Additions to the Standards... Summary of Revisions to... Members of the Professional...

 
Vivian Fonseca, MD, Chair

George L. Bakris, MD

Evan M. Benjamin, MD

Lawrence Blonde, MD

Jackie Boucher, MS, RD, LD, CDE

Fred L. Brancati, MD, MHS

John B. Buse, MD, PhD, Past chair

Kenneth Copeland, MD

Marjorie L. Cypress, MS, RN, CDE

Irl Hirsch, MD

Steven Kahn, MB, ChB

M. Sue Kirkman, MD

James Meigs, MD, MPH

Michael P. Pignone, MD, MPH

Victor L. Roberts, MD, MBA, CDE

Judith Wylie-Rossett, RD, EdD

Nathaniel G. Clark, MD, MS, RD (Staff)

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This Article Extract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                What's this?